Successful long-term therapy with flecainide in a family with paramyotonia congenita

Affiliations

¹ Department of Experimental Medicine and Surgery, Division of Clinical Biochemistry, University of Rome Tor Vergata, Roma, Lazio, Italy.
² Department of Medicine, Surgery, Neurology, Metabolic and Aging Science, Reference Center for Neurological and Neuromuscular Rare Disease, Università degli Studi della Campania Luigi Vanvitelli, Napoli, Campania, Italy.
³ Molecular Genetics and Genomics Laboratory, Institute of Genetics and Biophysics, Adriano Buzzati Traverso, Italian National Research Council (CNR), Naples, Italy.
⁴ IRCCS, INM Neuromed, Pozzilli, Italy.
⁵ Division of Neurology, Local Health Unit of South Naples 3, Napoli, Campania, Italy.

^# Contributed equally.

Case Reports

Chiara Terracciano et al. J Neurol Neurosurg Psychiatry. 2018 Nov.

. 2018 Nov;89(11):1232-1234.

doi: 10.1136/jnnp-2017-317615. Epub 2018 Feb 27.

¹ Department of Experimental Medicine and Surgery, Division of Clinical Biochemistry, University of Rome Tor Vergata, Roma, Lazio, Italy.
² Department of Medicine, Surgery, Neurology, Metabolic and Aging Science, Reference Center for Neurological and Neuromuscular Rare Disease, Università degli Studi della Campania Luigi Vanvitelli, Napoli, Campania, Italy.
³ Molecular Genetics and Genomics Laboratory, Institute of Genetics and Biophysics, Adriano Buzzati Traverso, Italian National Research Council (CNR), Naples, Italy.
⁴ IRCCS, INM Neuromed, Pozzilli, Italy.
⁵ Division of Neurology, Local Health Unit of South Naples 3, Napoli, Campania, Italy.

^# Contributed equally.

No abstract available

Keywords: channels; emg; myotonia; pharmacology; quality of life.

Conflict of interest statement

Competing interests: None declared.